Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 15 | 0 | −15 |
| Shares | 1.13M | 0 | −1.13M (−100.0%) |
| Value | $77.6K | $0 | −$77.6K (−100.0%) |
New holders (0)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (15)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Jane Street Group, LLC | 563,594 | $38.9K |
| HRT Financial LP | 137,515 | $9.00K |
| UBS Group AG | 119,072 | $8.22K |
| Geode Capital Management, LLC | 108,180 | $7.47K |
| XTX Topco Ltd | 90,905 | $6.28K |
| Two Sigma Securities, LLC | 61,345 | $4.24K |
| Vanguard Group Inc | 31,811 | $2.19K |
| BlackRock, Inc. | 16,128 | $1.11K |
| Morgan Stanley | 704 | $48 |
| SBI Securities Co., Ltd. | 320 | $22 |
| National Bank of Canada | 200 | $14 |
| Advisor Group Holdings, Inc. | 200 | $14 |
| Bank of America Corp | 79 | $5 |
| Group One Trading, L.P. | 79 | $5 |
| Tower Research Capital LLC (TRC) | 11 | $1 |